Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of toll-like …

J Dai, Y Wang, H Wang, Z Gao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Toll-like receptors (TLRs) are key sensors that recognize the pathogen-associated
molecular patterns (PAMPs) of severe acute respiratory syndrome coronavirus 2 (SARS …

Inflammatory pathways in COVID‐19: mechanism and therapeutic interventions

Y Jiang, T Zhao, X Zhou, Y Xiang… - MedComm, 2022 - Wiley Online Library
Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis.
In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive …

Regulation of the immune system by the insulin receptor in health and disease

P Makhijani, PJ Basso, YT Chan, N Chen… - Frontiers in …, 2023 - frontiersin.org
The signaling pathways downstream of the insulin receptor (InsR) are some of the most
evolutionarily conserved pathways that regulate organism longevity and metabolism. InsR …

miRNAs: The Key Regulator of COVID‐19 Disease

LT Hardin, N Xiao - International Journal of Cell Biology, 2022 - Wiley Online Library
As many parts of the world continue to fight the innumerable waves of COVID‐19 infection,
SARS‐CoV‐2 continues to sculpt its antigenic determinants to enhance its virulence and …

Evaluation of adjunctive photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial

MA Vetrici, S Mokmeli, AR Bohm, M Monici… - Journal of …, 2021 - Taylor & Francis
Purpose Evidence-based and effective treatments for COVID-19 are limited, and a new
wave of infections and deaths calls for novel, easily implemented treatment strategies …

Coagulation disorders in sepsis and COVID-19—two sides of the same coin? A review of inflammation–coagulation crosstalk in bacterial sepsis and COVID-19

G Tuculeanu, EC Barbu, M Lazar… - Journal of Clinical …, 2023 - mdpi.com
Sepsis is a major cause of morbidity and mortality worldwide. Sepsis-associated coagulation
disorders are involved in the pathogenesis of multiorgan failure and lead to a subsequently …

Immunomodulatory approaches in managing lung inflammation in COVID‐19: a double‐edge sword

G Verma, M Dhawan, ARA Saied… - Immunity …, 2023 - Wiley Online Library
Introduction The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …

Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19

AM Altibi, B Pallavi, H Liaqat, AA Slota, R Sheth… - Scientific reports, 2021 - nature.com
Abstract Prisons in the United States have become a hotbed for spreading COVID-19 among
incarcerated individuals. COVID-19 cases among prisoners are on the rise, with more than …

Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2

AZ Abbasi, DA Kiyani, SM Hamid… - Journal of Medical …, 2021 - Wiley Online Library
Epidemiological data shows a discrepancy in COVID‐19 susceptibility and outcomes with
some regions being more heavily affected than others. However, the factors that determine …

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon

HC Hasselbalch, V Skov, L Kjær, C Ellervik… - Cytokine & growth factor …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits an interferon (IFN)
deficiency state, which aggravates the type I interferon deficiency and slow IFN responses …